ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTCBB: SNWV) (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced the presentation of preclinical research conducted by Maria Siemionow, MD, PhD, DSc, at Cleveland Clinic investigating the biologic mechanisms of Pulsed Acoustic Cellular Expression (PACE®) technology as it applies to the treatment of ischemic tissues (tissues with inadequate blood supply).
